Beyond Biotech - the podcast from Labiotech

This week on the podcast, we have a conversation with Fran Gregory, vice president of Emerging Therapies at Cardinal Health.

The discussion covers the company’s role in healthcare, biosimilars, the l…

BioSenic, a Belgian clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, will share data on its late-clinical asset JTA-004 at the Osteoarthritis Rese…

Freya Biosciences is a clinical-stage biotech company dedicated to reimagining women's health and redefining fertility for those previously deprived of options. 

With a focus on microbial immunotherap…

Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA.

The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein kno…

A US company, with its origins in South Korea, is using natural killer (NK) cells to treat Alzheimer’s disease, with remarkable results.

This week, we have a conversation with Dr Paul Song, CEO of NKG…

Eligo Bioscience is a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome. 

Its first target is moderate to severe acne vulgaris, an inf…

Vaxxinity, Inc. is a U.S.-based biotechnology company looking to develop vaccines for several hard-to-treat diseases such as Alzheimer’s and Parkinson’s. 

The company is pioneering a new class of medi…

Is there a connection between worms being eradicated from the gut in the early 20th Century and an increase in allergies and autoimmune disease?  

This week, we have a conversation with Holoclara CEO …

Jennifer Schranz is senior vice president and global head of rare diseases in the R&D division at Ipsen.

On the podcast this week, she discusses a breakthrough treatment for primary biliary cholerang…

On this week’s podcast we have a conversation with Jordi Mata-Fink, co-founder and chief executive officer of the newly-launched U.S. company Gate Bioscience.

00:45-01:06: About Gate Bioscience
01:06-…

Among other things, UK-headquartered company Phenotypeca has been working with the Bill & Melinda Gates Foundation to produce albumin for low and middle-income countries to reduce the costs of vaccin…

French company CellProthera has seen some remarkable results treating people who have had a heart attack.  On this week’s podcast, the company’s CEO Matthieu de Kalbermatten tells us how it works.

01:…

On today’s podcast, Jean-Philip Piquemal, the chief scientific officer and co-founder of Qubit Pharmaceuticals, explains how the company’s Atlas platform is leading the way to more effective and safe…

This week, our guest on the podcast is Jason C. Foster, CEO of Ori Biotech.

Ori is a London, U.K. and New Jersey, U.S. based manufacturing technology company pioneering flexible process discovery with…

This week, our guest on the podcast is Mark Kotter, founder of newly-created company clock.bio.

clock.bio, a sister company to bit.bio, which Kotter also founded and is the CEO of, aims to extend and …

This week, we speak to Artiva Biotherapeutics’ CEO, Fred Aslan, M.D.

The company has demonstrated the potential for efficacy and safety with natural killer (NK) cells in two cancer clinical trials. I…

Compared to the smallest mRNA molecule, which is 300 nucleotides long, the largest transfer RNAs (tRNA) is less than a third of the size at 76 nucleotides. 

Scientists at Alltrna are harnessing the un…

Disease X, a concept shrouded in mystery, represents the unknown pathogens that could unleash future epidemics or pandemics. 

In the wake of recent global health crises, our understanding of the profo…

Despite the huge commercial success of PD-1 inhibitors and widespread use of checkpoint inhibitors such as anti-PD-1 or anti-CTLA4, 70 to 80% of patients still experience limited or no response to ex…

This week’s podcast is sponsored by Vetter.

On this week’s episode, we have a conversation with Steve Worland, CEO of eFFECTOR Therapeutics.

eFFECTOR is a clinical-stage biopharmaceutical company pione…